Sabin Begins Marburg Vaccine Trial in U.S.
Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate,…